Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Acupressure for the Treatment of Raynaud's Phenomenon

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01784354
Recruitment Status : Completed
First Posted : February 5, 2013
Last Update Posted : June 12, 2013
Information provided by (Responsible Party):
Heather Gladue, DO, University of Michigan

Brief Summary:
The use of acupressure will be compared to targeted Raynaud's education and will evaluate the' frequency, duration and pain of Raynaud's attacks.

Condition or disease Intervention/treatment Phase
Primary Raynaud's Phenomeon Other: Acupressure Other: Acupressure dilatation Behavioral: education Not Applicable

Detailed Description:
Using a Raynaud's condition score, severity of tingling, numbness and pain of attacks, the number of attacks and patient and physician visual analog scale we will assess the effect of acupressure.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 23 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Acupressure in Raynaud's Phenomenon- A Pilot Study.
Study Start Date : January 2013
Actual Primary Completion Date : June 2013
Actual Study Completion Date : June 2013

Resource links provided by the National Library of Medicine

Arm Intervention/treatment
Placebo Comparator: Education
target education toward Raynaud's
Behavioral: education
Active Comparator: Acupressure
acupressure- dilatation
Other: Acupressure dilatation
Active Comparator: Acupressure relaxation
acupressure relaxation protocol
Other: Acupressure

Primary Outcome Measures :
  1. Decrease in number of Raynaud's attacks [ Time Frame: 1-2 years ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • > 18 years old
  • Have Raynauds phenomenon, with at least 4 attacks in the last week
  • on stable medications
  • Willing to attend study visits

Exclusion Criteria:

  • smoker
  • have a history of stroke, heart attack or irregular heart rhythm
  • uncontrolled blood pressure
  • physical or mental illness that would interfere with participating in the study

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT01784354

Layout table for location information
United States, Michigan
University of Michigan
Ann Arbor, Michigan, United States, 48109
Sponsors and Collaborators
University of Michigan
Layout table for additonal information
Responsible Party: Heather Gladue, DO, Principle Investigator, University of Michigan Identifier: NCT01784354    
Other Study ID Numbers: HUM00062868
First Posted: February 5, 2013    Key Record Dates
Last Update Posted: June 12, 2013
Last Verified: June 2013
Additional relevant MeSH terms:
Layout table for MeSH terms
Raynaud Disease
Peripheral Vascular Diseases
Vascular Diseases
Cardiovascular Diseases